Loading
AMEXHealthcareMedical - Devices
Latest quote
$12.25
+$0.10 · +0.82%
InfuSystem Holdings, Inc. delivers infusion pumps, along with associated products and support services, to clients across the United States and Canada. The enterprise operates through two principal divisions: Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). The ITS segment specializes in providing electronic ambulatory infusion devices and accompanying disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy facilities. These devices are crucial for managing various cancers, including colorectal cancer, as well as for pain management and other therapeutic needs. Moreover, the company markets, leases, and rents out a selection of new and pre-owned infusion pumps (both pole-mounted and ambulatory) and other vital durable medical equipment. It also sells consumables essential for treatment. InfuSystem further extends its offerings to include biomedical recertification, maintenance, and repair services for oncology practices and diverse alternative care settings, such as home care and home infusion providers, skilled nursing facilities, pain centers, and hospitals. Additionally, InfuSystem furnishes both local and field-based customer assistance and manages dedicated pump service and repair facilities. The company was founded in 2005 and maintains its corporate headquarters in Rochester Hills, Michigan.
Previous close
$12.25
+$0.10 · +0.82%
After-hours
$12.25
$0.00 · 0.00%
Sep 14, 4:01 PM ET
Regular session · ET · Market data may be delayed.
InfuSystem Holdings, Inc. delivers infusion pumps, along with associated products and support services, to clients across the United States and Canada. The enterprise operates through two principal divisions: Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). The ITS segment specializes in providing electronic ambulatory infusion devices and accompanying disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy facilities. These devices are crucial for managing various cancers, including colorectal cancer, as well as for pain management and other therapeutic needs. Moreover, the company markets, leases, and rents out a selection of new and pre-owned infusion pumps (both pole-mounted and ambulatory) and other vital durable medical equipment. It also sells consumables essential for treatment. InfuSystem further extends its offerings to include biomedical recertification, maintenance, and repair services for oncology practices and diverse alternative care settings, such as home care and home infusion providers, skilled nursing facilities, pain centers, and hospitals. Additionally, InfuSystem furnishes both local and field-based customer assistance and manages dedicated pump service and repair facilities. The company was founded in 2005 and maintains its corporate headquarters in Rochester Hills, Michigan.
Day range
Current $12.25
52-week range
Current $12.25
Regular session · ET · Market data may be delayed.
GoAI Score
Hold
Valuation
82
Deep Value
Sentiment
59
Mixed
Risk
50
Elevated Risk
Momentum
43
Neutral
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
InfuSystem Holdings, Inc. delivers infusion pumps, along with associated products and support services, to clients across the United States and Canada. The enterprise operates through two principal divisions: Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). The ITS segment specializes in providing electronic ambulatory infusion devices and accompanying disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy facilities. These devices are crucial for managing various cancers, including colorectal cancer, as well as for pain management and other therapeutic needs. Moreover, the company markets, leases, and rents out a selection of new and pre-owned infusion pumps (both pole-mounted and ambulatory) and other vital durable medical equipment. It also sells consumables essential for treatment. InfuSystem further extends its offerings to include biomedical recertification, maintenance, and repair services for oncology practices and diverse alternative care settings, such as home care and home infusion providers, skilled nursing facilities, pain centers, and hospitals. Additionally, InfuSystem furnishes both local and field-based customer assistance and manages dedicated pump service and repair facilities. The company was founded in 2005 and maintains its corporate headquarters in Rochester Hills, Michigan.
Day range
Current $12.25
52-week range
Current $12.25
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 143.44M USD | 134.86M USD | 125.79M USD | 109.91M USD | 102.38M USD |
| Cost of goods sold | 63.14M USD | 64.46M USD | 62.68M USD | 49.35M USD | 43.85M USD |
| Gross profit | 80.3M USD | 70.4M USD | 63.11M USD | 60.56M USD | 58.54M USD |
| Selling, general, and administrative | 67.46M USD | 62.52M USD | 58.03M USD | 56.41M USD | 51.45M USD |
| Operating expenses | 68.38M USD | 63.51M USD | 59.02M USD | 58.91M USD | 55.72M USD |
| Interest expense | 1.3M USD | 1.78M USD | 2.17M USD | 1.4M USD | 1.38M USD |
| Depreciation and amortization | 13.29M USD | 12.5M USD | 12.51M USD | 13.36M USD | 14.63M USD |
| Operating income | 11.92M USD | 6.89M USD | 4.09M USD | 1.65M USD | 2.82M USD |
| Net income | 6.63M USD | 2.35M USD | 872K USD | 18K USD | 1.42M USD |
Company facts updated Sep 15, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Average target
$15.00
22.45% upsideLimited analyst sample: 4 ratings. Interpret the distribution with caution.
Funds reporting this stock among their holdings, ordered by reported position size.
Avantis U.S. Small Cap Value ETFAVUV9.27M0.03%31.79B USD0.25%$124.02-0.39%
iShares Russell 2000 ETFIWM5.33M0.01%78.38B USD0.19%$287.91-0.34%
Vanguard Morningstar Total Stock Market ETFVTI5M0.00%2.3T USD0.03%$374.68-0.43%
iShares Russell 2000 Growth ETFIWO2.2M0.02%14.39B USD0.24%$365.6-0.55%
Vanguard Extended Market ETFVXF2.09M0.00%93.7B USD0.05%$236.92-0.35%
Vanguard Russell 2000 ETFVTWO994.72K0.01%17.4B USD0.06%$116.37-0.33%
Dimensional - US Small Cap ETFDFAS816.24K0.01%15.49B USD0.26%$80.16-0.45%
iShares Micro-Cap ETFIWC797.68K0.06%1.44B USD0.60%$190.92+0.04%Avantis U.S. Small Cap Value ETFAVUViShares Russell 2000 ETFIWMVanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 Growth ETFIWOVanguard Extended Market ETFVXFVanguard Russell 2000 ETFVTWODimensional - US Small Cap ETFDFASiShares Micro-Cap ETFIWCAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
